Feasibility of developing and exporting novel fungal strains for the mould ripened cheese market in Italy

Myconeos已经开发出突破性的技术来自然培育新的真菌菌株。我们应用该技术培育了40年来市场上第一批用于蓝干酪应用的罗克福青霉新菌株。这些新品系是通过在英式蓝色奶酪和英国消费者工作中进行评估而选出的。这四个新的英国商业品系提供了所需的感官属性，以吸引新的消费者进入该类别，并解决了现有品系目前无法获得的感官特征。例如，没有苦味或白垩质口感的淡味蓝色奶酪和浓郁的蓝色奶酪。英国市场只占全球蓝纹奶酪销量的5%，欧洲大陆和北美是最大的机会。三个欧洲国家的产量和销售额占了大部分，Myconeos正瞄准意大利。我们将探索为意大利和欧洲的霉菌成熟干酪市场生产新的真菌菌株的可行性，重点是戈尔贡佐拉和多拉塔。制造这些蓝色奶酪需要的成熟时间比斯蒂尔顿和其他英国风格的蓝色奶酪要长得多。因此，可能需要生长速度较慢、蛋白质分解能力较低的新菌株。通过与意大利的潜在合作伙伴接触，Myconeos将更好地了解制造商和消费者的市场需求和机会，重点研究和开发下一代真菌菌株，并强调新菌株开发可能满足的那些未得到满足的需求。附加值将把萨科和伊吉亚视为潜在的通行费制造商和进一步的销售和分销合作伙伴，进行全球销售。

Myconeos has developed ground breaking technology to naturally breed new fungal strains. We have applied the technology to breed the first new penicillium roqueforti strains in the market for blue cheese application in forty years. These new strains have been selected through evaluation in UK style blue cheeses and consumer work in the UK. The four new UK commercial strains provide desired sensory attributes to attract new consumers into the category and address sensory profiles currently unobtainable with the established strains examples include a mild flavoured blue cheese without bitterness or a chalky mouthfeel and an intense blue cheese. The UK market only accounts for 5% of the blue cheese sales worldwide with the big opportunities being mainland Europe and north america. Three European countries account for the majority of production and sales and Myconeos is targetting Italy. We will explore the feasibility of producing new strains of fungi for the mould ripened cheese market in Italy and Europe with a focus on gorgonzola and dolcelatte. Manufacturing of these blue cheese requires significantly longer maturation times than Stiltons and other UK style blue cheeses. Thus new strains that have reduced growth rates and lower proteolysis maybe needed. Through engagement with potential partners in Italy, Myconeos will better understand the market needs and opportunities at both manufacturers and with consumers and develop a focussed research and development for the next generation fungal strains and also highlight those unmet needs that new strain development could potentially meet. Added value will be to look at SACCO and IGEA as a potential toll manufacturers and further sales and distribution partners for global sales.